10
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Discovery of a mcr-1-bearing plasmid in commensal colistin-resistant Escherichia coli from healthy broilers in Faisalabad, Pakistan

      letter

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Letter to the editor Polymyxins, like colistin (polymyxin E), are a group of cationic antimicrobial cyclic polypeptide, which have been extensively-used as prophylactic feed additives in animal production since the 1960s [1]. A strong association has especially been drawn between antimicrobial use and resistance in poultry and pig farms [2–5]. The advent and rise of multi-drug resistant bacteria has now prompted the re-introduction of colistin as a last-resort treatment option in human medicine [6,7]. However, the recent emergence and diversity of plasmid-borne mobile colistin resistance determinants (mcr-1 to mcr-5) in Enterobacteriaceae has severely challenged its use in a clinical setting [8–12]. In the past two years, mcr-1 has been detected in over 40 countries across 5 of 7 continents worldwide [13–15]. Except rare cases of chromosomally-integrated mcr-1 [16,17], its prevalent transmission relies on the transfer by diversified plasmids of different replication incompatibilities [18,19]. Mechanistically, the mcr-1 gene that encodes phosphoethanolamine transferase mediates the modification of the lipopolysaccharide layer (LPS) of the outer membrane of Gram-negative bacteria through the addition of phosphoethanolamine (PEA) to the 1 (or 4′)-phosphate position of lipid A moieties [20,21]. This reduces the affinity of polymyxin antibiotics to their primary target, the LPS layer. Since its discovery during routine surveillance in China [8], increasingly-accumulated evidence suggested the presence of mcr-1-bearing bacteria in food producing animals and humans across the world. To the best of our knowledge, the leading two types of mcr-1-harboring plasmids referred to IncI2 [8,18,22,23] and IncX4 [24–26], have greatly facilitated global dissemination of mcr-1 colistin resistance [14,27]. In Pakistan, the mcr-1 gene has been identified in Escherichia coli (E. coli) isolates from human [28], wildlife [29] and a broiler suffering from colibacillosis [30]. However, little is known about the prevalence of mcr-1 and its genetic environment in commensal E. coli isolates from poultry in Pakistan. From December 2016 to January 2017, cloacal swabs from a total of 100 healthy broiler chicken were obtained from four commercial farms (n = 25 each) in the Faisalabad region of Pakistan. To screen the colistin resistant E. coli, all the samples were seeded directly onto MacConkey agar supplemented with 4 μg/ml of colistin and were incubated at 37°C for 24 hours. Of 100 birds, colistin resistant E. coli were found in only 8 (8%) samples. A single colony of E. coli was selected per sample and identified using API 20E biochemical strips (bioMérieux, Marcy l'Etoile, France). The presence of mcr-1 gene was confirmed among all 8 E. coli isolates by conventional PCR as we recently conducted [19,31]. Subsequently, the minimum inhibitory concentration (MIC) of colistin among these strains was tested by micro-dilution according to the guidelines of Clinical and Laboratory Standards Institute [32,33]. The mcr-1-positive E. coli gave MIC of colistin between 2–8 μg/ml (Table 1). Plasmids were extracted from mcr-1-positive E. coli using alkaline lysis method. To elucidate the genetic context of mcr-1 on these plasmids, the conventional multiplex PCR with 7 primer sets was performed (Table S1) as we recently described [3,19]. The plasmids isolated from the different strains had unexpectedly similar PCR profiles with the exception of pPK112 which lacks the tnpA loci (Fig. 1B). Genetic context of mcr-1 shows that all the plasmids lack the insertion element ISApl1 (Fig. 1A), which has been responsible for insertion of mcr-1 in previous studies [34]. Also, these plasmids (Fig. 1A) are identical to the mcr-1-carrying plasmid pE15017 isolated in China [19,22]. These bacteria were subjected to multi-locus sequence typing analyses with the Warwick method (http://mlst.warwick.ac.uk/mlst/). Diversified sequence types were detected, namely, ST10, ST2847, ST155, ST361 and ST6395. Evidently, all strains belonged to different STs with the exception of two strains of ST361 (Table 1). Despite that none of these STs have been reported from Pakistan in the past, ST10 and ST155 have been reported in mcr-1-harboring E. coli isolated from chicken in China [17,35]. Table 1. Characteristics of mcr-1-positive E. coli isolates from healthy broilers in Faisalabad, Pakistan. Strains Source Date MIC (μg/ml) MLST Farm no. PK102 cloacal 27/12/2016 ≥8 ST10 1 PK103 cloacal 27/12/2016 ≥4 ST2847 1 PK105 cloacal 27/12/2016 ≥8 ST155 1 PK107 cloacal 27/12/2016 ≥8 New ST 1 PK109 cloacal 27/12/2016 ≥4 ST361 1 PK110 cloacal 30/01/2017 ≥4 ST6395 3 PK111 cloacal 30/01/2017 ≥2 ST361 3 PK112 cloacal 30/01/2017 ≥8 New ST 3 Figure 1. Genetic analyses of mcr-1-harboring plasmids in this study A. Scheme of different mcr-1-bearing plasmids B. PCR assays of mcr-1 and neighboring loci in plasmids 16S rDNA is specific to the E. coli specie. Subsequently, a representative mcr-1-carrying plasmid pPK105 (Table 1) was subjected to whole genome sequencing using the method of Illumina HiSeq X-ten. The plasmid sequences were annotated by RAST, and the genome maps were drawn with the Circos program. As a result, the genome size of pPK105 was determined to be 60.499 kb (Acc. no.: MG808035, Fig. 2A), encoding hundreds of open reading frames with a GC content of 42.3%. Unlike the prevalent IncX4 type plasmid reported in Pakistan, Plasmid Finder at the web server (https://cge.cbs.dtu.dk/services/PlasmidFinder/) indicated that pPK105 is a member of IncI2-type plasmid family (Fig. 2B). Notably, mcr-1 is the only resistance gene detected in pPK105 (Fig. 2B). It is quite different from the scenarios observed in the other mcr-1-containing Pakistan isolate coharboring ESBL (extended-spectrum β-lactamase gene) and heavy-metal resistance. Although that ISApl1 sequence is missing, pPK105 retains the two conjugative genes vir and pil (Fig. 2). Intriguingly, we noticed that the mcr-1 gene in pPK105 is next to a sdrl gene, a serine-aspartate repeat surface protein known to bind collagen (Fig. 2B). However, its relevance remains unclear. Nevertheless, it has been shown earlier that ISApl1 transposon element is highly unstable in IncI2 plasmid [36]. Figure 2. The representative mcr-1-bearing plasmid in a colistin resistant E. coli isolate PK105 A. Diagram for the mcr-1-positive plasmid (pPK105) that exists in the E. coli isolate PK105 B. Colinear comparison of the IncI2-type plasmid pPK105 with two closely-related plasmids mcr-1-postive M18 and mcr-1-negative pColR644SK1. For further investigation, the chemical modification of lipid A by the mcr-1 protein product MCR-1, the bacterial LPS was extracted as we conducted earlier [20,37] and then subjected to matrix-assisted laser desorption ionization–time of flight mass spectrometry (MALDI-TOF MS) [38]. In comparison to E. coli MG1655 (m/z 1796.29, Fig. 3A), a shift in the predominant lipid A species (m/z 1920.136, Fig. 3A) was observed in the mcr-1-expressing PK105 strain (Δmass is close to 123) corresponding to the addition of a PEA moiety (Fig. 3B). This new peak corresponds to a single modification that may occur at either the 1 or the 4′ position (Fig. 3B). This highlighted that surface remodeling by the mcr-1-encoding phosphoethanolamine transferase contributes to the resultant colistin resistance [14]. Figure 3. MALDI-TOF MS analyses of lipid A pools of E. coli strains with (or without) mcr-1 A. MS profile of the LPS-lipid A in the negative control strain E. coli MG1655 B. MS spectrum of the LPS-lipid A in PK105, a representative strain of E. coli carrying mcr-1. A single modification may occur at the 1 (or 4′) position. The position indicated here is suggestive [20]. The discovery of the mcr-1 gene, prompted a shift in focus from chromosomal mutations causing colistin-resistance to a transmissible plasmid-borne colistin resistance determinant. In addition to clinical isolates in humans, antimicrobial surveillance programs in Europe have identified mcr-1 in commensal bacterial populations from broilers, pigs and turkeys [39]. This study shows a similar threatening scenario in the Faisalabad region of Pakistan where high rates of mcr-1 positive E. coli were identified in healthy broilers. Retrospectively, the discovery of diverse clonal backgrounds of E. coli harboring the plasmid-borne mcr-1 is similar to scenarios observed earlier in Chinese poultry. Similarly, data on global population structure of mcr-1-positive E. coli showed large diversity in STs but limited plasmid types, particularly with regional spread of IncHI2 plasmids in Europe and IncI2 in Asia [14]. This indicated the possible spread of a single mcr-1 colistin resistance gene across large geographical distances. It seems likely that farm animals act as a reservoir for the genetic diversity of mcr-1 [40]. Supplementary Material 1462060.zip

          Related collections

          Most cited references33

          • Record: found
          • Abstract: found
          • Article: not found

          Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections.

          The emergence of multidrug-resistant gram-negative bacteria and the lack of new antibiotics to combat them have led to the revival of polymyxins, an old class of cationic, cyclic polypeptide antibiotics. Polymyxin B and polymyxin E (colistin) are the 2 polymyxins used in clinical practice. Most of the reintroduction of polymyxins during the last few years is related to colistin. The polymyxins are active against selected gram-negative bacteria, including Acinetobacter species, Pseudomonas aeruginosa, Klebsiella species, and Enterobacter species. These drugs have been used extensively worldwide for decades for local use. However, parenteral use of these drugs was abandoned approximately 20 years ago in most countries, except for treatment of patients with cystic fibrosis, because of reports of common and serious nephrotoxicity and neurotoxicity. Recent studies of patients who received intravenous polymyxins for the treatment of serious P. aeruginosa and Acinetobacter baumannii infections of various types, including pneumonia, bacteremia, and urinary tract infections, have led to the conclusion that these antibiotics have acceptable effectiveness and considerably less toxicity than was reported in old studies.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections.

            Increasing multidrug resistance in Gram-negative bacteria, in particular Pseudomonas aeruginosa, Acinetobacter baumannii, and Klebsiella pneumoniae, presents a critical problem. Limited therapeutic options have forced infectious disease clinicians and microbiologists to reappraise the clinical application of colistin, a polymyxin antibiotic discovered more than 50 years ago. We summarise recent progress in understanding the complex chemistry, pharmacokinetics, and pharmacodynamics of colistin, the interplay between these three aspects, and their effect on the clinical use of this important antibiotic. Recent clinical findings are reviewed, focusing on evaluation of efficacy, emerging resistance, potential toxicities, and combination therapy. In the battle against rapidly emerging bacterial resistance we can no longer rely entirely on the discovery of new antibiotics; we must also pursue rational approaches to the use of older antibiotics such as colistin.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              Novel Plasmid-Mediated Colistin Resistance Gene mcr-3 in Escherichia coli

              ABSTRACT The mobile colistin resistance gene mcr-1 has attracted global attention, as it heralds the breach of polymyxins, one of the last-resort antibiotics for the treatment of severe clinical infections caused by multidrug-resistant Gram-negative bacteria. To date, six slightly different variants of mcr-1, and a second mobile colistin resistance gene, mcr-2, have been reported or annotated in the GenBank database. Here, we characterized a third mobile colistin resistance gene, mcr-3. The gene coexisted with 18 additional resistance determinants in the 261-kb IncHI2-type plasmid pWJ1 from porcine Escherichia coli. mcr-3 showed 45.0% and 47.0% nucleotide sequence identity to mcr-1 and mcr-2, respectively, while the deduced amino acid sequence of MCR-3 showed 99.8 to 100% and 75.6 to 94.8% identity to phosphoethanolamine transferases found in other Enterobacteriaceae species and in 10 Aeromonas species, respectively. pWJ1 was mobilized to an E. coli recipient by conjugation and contained a plasmid backbone similar to those of other mcr-1-carrying plasmids, such as pHNSHP45-2 from the original mcr-1-harboring E. coli strain. Moreover, a truncated transposon element, TnAs2, which was characterized only in Aeromonas salmonicida, was located upstream of mcr-3 in pWJ1. This ΔTnAs2-mcr-3 element was also identified in a shotgun genome sequence of a porcine E. coli isolate from Malaysia, a human Klebsiella pneumoniae isolate from Thailand, and a human Salmonella enterica serovar Typhimurium isolate from the United States. These results suggest the likelihood of a wide dissemination of the novel mobile colistin resistance gene mcr-3 among Enterobacteriaceae and aeromonads; the latter may act as a potential reservoir for mcr-3.
                Bookmark

                Author and article information

                Journal
                Virulence
                Virulence
                KVIR
                kvir20
                Virulence
                Taylor & Francis
                2150-5594
                2150-5608
                2018
                21 June 2018
                21 June 2018
                : 9
                : 1
                : 994-999
                Affiliations
                [a ]School of Food and Biological Engineering, Shaanxi University of Science and Technology , Xi'an, Shaanxi, China
                [b ]Institute of Microbiology, University of Agriculture , Faisalabad, Pakistan
                [c ]Department of Medical Microbiology and Parasitology, Zhejiang University School of Medicine , Hangzhou, Zhejiang, China
                [d ]Department of Biochemistry, University of Illinois , Urbana, USA
                [e ]College of Animal Sciences, Zhejiang University , Hangzhou, Zhejiang, China
                Author notes
                CONTACT Youjun Feng fengyj@ 123456zju.edu.cn Room C519, Building of Science & Research, Zhejiang University School of Medicine , No. 866, Yu-Hang-Tang, Xihu District, Hangzhou City, Zhejiang 310058, China
                [#]

                These authors contributed equally to this work.

                Supplemental data for this article can be accessed on the publisher's website.

                Article
                1462060
                10.1080/21505594.2018.1462060
                6037438
                29667494
                75cbce50-7955-40ab-b3c9-780bb7c21293
                © 2018 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group

                This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

                History
                : 28 February 2018
                : 3 April 2018
                Page count
                Figures: 3, Tables: 1, Equations: 0, References: 40, Pages: 6
                Funding
                Funded by: National Natural Science Foundation of China 10.13039/501100001809
                Award ID: 31570027 & 81772142
                Funded by: “Young 1000 Talents” Award of China
                Funded by: National Key R&D Program of China
                Award ID: 2017YFD0500202
                Funded by: National Key Basic Research Program of China
                Award ID: 2016YFC1200100
                This work was supported by National Key R&D Program of China (2017YFD0500202, YF), National Key Basic Research Program of China (2016YFC1200100, YF), and National Natural Science Foundation of China (31570027 & 81772142, YF). Dr. Feng is a recipient of the “Young 1000 Talents” Award.
                Categories
                Letter

                Infectious disease & Microbiology
                colistin resistance,enteric bacteria,gut microbiome,inci2,lipid a,mcr-1,pakistan,poultry

                Comments

                Comment on this article